Industry Roundup: GMP Warning, MedGen/Alternaturals Merger
This article was originally published in The Tan Sheet
Executive Summary
FDA finds chaos at Chaotic Labz; investor facilitates MedGen, Alternaturals combination; more news in brief.
You may also be interested in...
FDA Holds Marketers Responsible For Manufacturers’ GMP Violations
FDA has begun holding own-label dietary supplement marketers responsible for their contract manufacturers’ violations of good manufacturing practices.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.